Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xaliproden for Oxaliplatin-induced PSN in Colon Cancer
NCT00603577Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Jan 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of xaliproden in peripheral sensory neuropathy, sponsored by Sanofi. Started Jan 2008; status: terminated.
02
Drugs
xaliproden
03
Conditions
peripheral sensory neuropathy
Beyond the preview
Go deeper on NCT00603577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603577.